DONATE NOW
ENEWS SIGN-UP

Casma to Develop CSM-101 as Treatment for Parkinson’s

Jun 13, 2025 | General Interest

Shared from parkinsonsnewstoday.com.     Casma Therapeutics said it will develop CSM-101 as a potential disease-modifying oral treatment for people with Parkinson’s disease and Gaucher disease. CSM-101 is a first-in-class small molecule designed to activate the...

Brain-Region Stimulation May Ease Motor Symptoms

Jun 13, 2025 | Research

Shared from parkinsonsnewstoday.com.     Stimulating nerve cells in a region of the brain involved in processing sound and emotions may help ease motor symptoms such as those caused by Parkinson’s disease, without unwanted side effects on emotional response, according...

Patients in Pilot Study See Promise In Equine-Assisted Therapy

Jun 13, 2025 | Research

Shared from parkinsonsnewstoday.com.     Parkinson’s disease patients in a pilot study testing the effects of equine-associated therapy report that they enjoy working with horses, while researchers say they hope results from the program will provide evidence of its...